Barrès and colleagues showed that, in skeletal muscle from patients with T2DM, DNMT3-related non-CpG hypermethylation occurred in the PGC-1α promoter, which resulted in decreased PGC-1α gene expression and mtDNA levels [85]. The gene discussed is PPARGC1A; the disease is type 2 diabetes mellitus.